Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Enanta Pharmaceuticals patents Mpro inhibitors for coronovirus infections

June 10, 2022

Cilagicin, next-generation antibiotic with activity against MDR isolates

June 9, 2022

Targeting NLRP3 inflammasome pathway prevents C. septicum-induced lethality

June 8, 2022

Novel fungal Hsp90 inhibitors for the treatment of azole-resistant candidiasis

June 7, 2022

Molecule "superglues" itself to enzyme to fight all stages of malaria parasite

June 7, 2022

MARCH8 attenuates cGAS-mediated innate autoimmune responses

June 3, 2022

Expanded collaboration research on COVID-19 protease inhibitors

June 2, 2022

Olverembatinib, ponatinib identified as possible treatments for COVID-related cytokine storm

June 1, 2022

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

May 31, 2022

Engineered CAR NK cells can be an effective therapy against SARS-CoV-2 infection

May 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...